KEY
33
-4
CSX
39
-4
BLK
54
4
WAT
52
-2
DHI
44
-4
OMC
55
-7
EXPE
58
-3
FTI
82
-7
K
39
-5
LH
48
-5
CB
44
-3
COF
65
-2
WRK
63
-5
PDCO
44
-5
HCP
84
-2
CA
12
-8
NFLX
59
2
DO
39
-17
WMT
62
-5
STI
32
-26
KEY
33
-4
CSX
39
-4
BLK
54
4
WAT
52
-2
DHI
44
-4
OMC
55
-7
EXPE
58
-3
FTI
82
-7
K
39
-5
LH
48
-5
CB
44
-3
COF
65
-2
WRK
63
-5
PDCO
44
-5
HCP
84
-2
CA
12
-8
NFLX
59
2
DO
39
-17
WMT
62
-5
STI
32
-26
Financhill
Back

Phathom Pharmaceuticals Vs. Lixte Biotechnology Holdings Industry Stock Comparison

Buy
51

PHAT
Phathom Pharmaceuticals

Last Price:
9.26
Seasonality Move:
-5.3%
Sell
34

LIXT
Lixte Biotechnology Holdings

Last Price:
2.87
Seasonality Move:
28.71%
Buy
51
Phathom Pharmaceuticals (PHAT) is a Buy

Is Phathom Pharmaceuticals a Buy, Sell or Hold?

  • The current Phathom Pharmaceuticals [PHAT] share price is $9.04. The Score for PHAT is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
  • PHAT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
34
Lixte Biotechnology Holdings (LIXT) is a Sell

Is Lixte Biotechnology Holdings a Buy, Sell or Hold?

  • The current Lixte Biotechnology Holdings [LIXT] share price is $2.76. The Score for LIXT is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • LIXT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PHAT Stock Price Chart

What is Phathom Pharmaceuticals's stock price today?

  • The Phathom Pharmaceuticals share price today is $9.04
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PHAT is experiencing selling pressure, which indicates risk of future bearish movement.

LIXT Stock Price Chart

What is Lixte Biotechnology Holdings's stock price today?

  • The Lixte Biotechnology Holdings share price today is $2.76
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LIXT is experiencing selling pressure, which indicates risk of future bearish movement.

PHAT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.21 Sell
Relative Strength Index (14 RSI): 42.22 Sell
Chaikin Money Flow: -215488 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.19 - 10.97) Sell
Bollinger Bands (100): (7.49 - 10.21) Buy

LIXT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.06 Buy
Relative Strength Index (14 RSI): 40.55 Sell
Chaikin Money Flow: -18614 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.04 - 3.58) Sell
Bollinger Bands (100): (2 - 3.04) Buy

PHAT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.1 Sell
20-day SMA: 9.98 Sell
50-day SMA: 9.82 Sell
200-day SMA: 10.09 Sell
8-day EMA: 9.27 Sell
20-day EMA: 9.6 Sell
50-day EMA: 9.49 Sell
200-day EMA: 9.7 Sell

LIXT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.21 Sell
20-day SMA: 3.31 Sell
50-day SMA: 2.86 Sell
200-day SMA: 2.63 Buy
8-day EMA: 3.15 Sell
20-day EMA: 3.18 Sell
50-day EMA: 2.95 Sell
200-day EMA: 3.27 Sell

Phathom Pharmaceuticals Earnings Growth & PHAT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $0.15 per share, a decrease this year of $0.75 per share, and an increase next year of $1.24 per share.

Lixte Biotechnology Holdings Earnings Growth & LIXT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Phathom Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Lixte Biotechnology Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):